Free Trial

Boothbay Fund Management LLC Lowers Stock Position in American Healthcare REIT, Inc. $AHR

American Healthcare REIT logo with Finance background

Key Points

  • Boothbay Fund Management LLC reduced its stake in American Healthcare REIT by 18.3%, selling 53,592 shares and now owns approximately $7.23 million worth of the stock.
  • Multiple brokerage firms have projected growth for the stock, with JMP Securities raising its price target from $40 to $45, giving it a "market outperform" rating.
  • American Healthcare REIT recently announced a quarterly dividend of $0.25 per share, resulting in an annualized yield of 2.4% despite a high dividend payout ratio of -454.55%.
  • Interested in American Healthcare REIT? Here are five stocks we like better.

Boothbay Fund Management LLC decreased its position in shares of American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 18.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 238,650 shares of the company's stock after selling 53,592 shares during the period. Boothbay Fund Management LLC owned approximately 0.15% of American Healthcare REIT worth $7,231,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in AHR. The Manufacturers Life Insurance Company raised its position in shares of American Healthcare REIT by 118.8% during the 4th quarter. The Manufacturers Life Insurance Company now owns 48,586 shares of the company's stock valued at $1,381,000 after buying an additional 26,378 shares in the last quarter. Northern Trust Corp raised its position in shares of American Healthcare REIT by 99.0% during the 4th quarter. Northern Trust Corp now owns 1,732,882 shares of the company's stock valued at $49,249,000 after buying an additional 861,882 shares in the last quarter. Algert Global LLC purchased a new stake in shares of American Healthcare REIT during the 4th quarter valued at about $3,732,000. Ameriprise Financial Inc. raised its position in shares of American Healthcare REIT by 26.9% during the 4th quarter. Ameriprise Financial Inc. now owns 95,974 shares of the company's stock valued at $2,728,000 after buying an additional 20,366 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its position in shares of American Healthcare REIT by 480.5% during the 4th quarter. BNP Paribas Financial Markets now owns 98,883 shares of the company's stock valued at $2,810,000 after buying an additional 81,848 shares in the last quarter. Hedge funds and other institutional investors own 16.68% of the company's stock.

Insider Transactions at American Healthcare REIT

In other news, CIO Stefan K.L. Oh sold 3,860 shares of the stock in a transaction dated Monday, June 30th. The shares were sold at an average price of $36.10, for a total transaction of $139,346.00. Following the sale, the executive directly owned 95,671 shares of the company's stock, valued at $3,453,723.10. This represents a 3.88% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Mark E. Foster sold 3,850 shares of the business's stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total transaction of $161,276.50. Following the sale, the executive vice president directly owned 59,100 shares of the company's stock, valued at $2,475,699. This represents a 6.12% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.00% of the company's stock.

American Healthcare REIT Stock Up 0.2%

AHR traded up $0.10 on Monday, hitting $42.83. The company had a trading volume of 984,191 shares, compared to its average volume of 1,630,996. The stock has a fifty day moving average price of $39.36 and a 200-day moving average price of $34.58. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.48 and a current ratio of 0.48. American Healthcare REIT, Inc. has a 12-month low of $21.87 and a 12-month high of $43.22. The stock has a market capitalization of $7.22 billion, a price-to-earnings ratio of -194.66, a P/E/G ratio of 2.19 and a beta of 1.09.

American Healthcare REIT (NYSE:AHR - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.42 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.02. The company had revenue of $542.50 million during the quarter, compared to analysts' expectations of $539.49 million. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%.The firm's revenue was up 7.5% compared to the same quarter last year. During the same period last year, the business posted $0.33 earnings per share. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. Analysts predict that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.

American Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 18th. Shareholders of record on Monday, June 30th were paid a dividend of $0.25 per share. The ex-dividend date was Monday, June 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.3%. American Healthcare REIT's dividend payout ratio (DPR) is presently -454.55%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on AHR. Royal Bank Of Canada lifted their price target on shares of American Healthcare REIT from $39.00 to $45.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 13th. KeyCorp lifted their price target on shares of American Healthcare REIT from $34.00 to $40.00 and gave the stock an "overweight" rating in a research note on Wednesday, June 11th. Robert W. Baird started coverage on American Healthcare REIT in a research report on Friday, July 18th. They set an "outperform" rating and a $41.00 target price for the company. Truist Financial raised their price target on shares of American Healthcare REIT from $44.00 to $46.00 and gave the stock a "buy" rating in a research note on Tuesday, August 26th. Finally, Scotiabank reaffirmed an "outperform" rating on shares of American Healthcare REIT in a research note on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating and ten have given a Buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $41.89.

Check Out Our Latest Report on American Healthcare REIT

American Healthcare REIT Profile

(Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Further Reading

Institutional Ownership by Quarter for American Healthcare REIT (NYSE:AHR)

Should You Invest $1,000 in American Healthcare REIT Right Now?

Before you consider American Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.

While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.